Table 1.

Categorical arrangements for the different cell types in 160 rectal cancer patients.

cell type (antibody)		intratumoral			peritumoral
		cells / mm2		% of patients	cells / mm2		% of patients
eosinophils	(EG-2)		n = 159			n = 140
	none/few	0-10		29	0-50		31
	moderate	11-50		50	51 - 200		43
	many	> 50		21	> 200		26
neutrophils	(elastase)		n = 160			n = 152
	none/few	0-5		21	0 - 75		24
	moderate	6 - 50		54
	many	> 50		25	> 75		76
mast cells	(tryptase)		n= 160			n = 151
	none/few	0 -5		19	0-30		25
	moderate	6 -50		52	31 -100		59
	many	> 50		29	> 100		16
macrophages	(CD68)		n = 159
	none/few	0-50		28
	moderate	51 -150		50
	many	> 150		22
NK cells	(CD56)		n = 159			n = 136
	none	0		33	0		43
	moderate/many	> 0		67	> 0		57
T cells	(CD3)		n = 158			n = 157
	none/few	0-55		27	0-300		20
	moderate	56-105		36	301 - 500		51
	many	>105		37	> 500		29
CD4+ cells			n = 156			n = 130
	none/few	0-30		43	0-20		24
	moderate	31 -65		26	21 -110		50
	many	>65		31	> 110		26
CD8+ cells			n = 159			n = 122
	none/few	0-15		26	0-135		77
	moderate	16-75		47
	many	>75		27	> 135		23

Peritumoral infiltrate could not be reliably determined in all patients, because of the absence of invasive front in several tumor samples.